Treatment matched to your tumour.
Two cancers with the same name can behave very differently. In precision oncology, we read your tumour's genetic and molecular makeup, so that your treatment is chosen for its biology, instead of a standard protocol used for every case with that diagnosis.
Matched to your cancer's biology.
Two people with the same diagnosis — even the same type of breast cancer — can have tumours driven by completely different biology.
We test for that biology directly. Genetic and molecular profiling shows what's actually driving your tumour, and that result can shape your whole plan: which drugs to use, in what order, and which ones to skip because they're unlikely to work for your specific cancer — sparing you their cost and side effects for no benefit.
Know what's likely to work, before you start.
Testing first tells you whether a targeted therapy or immunotherapy is likely to work for your tumour, so you're deciding on evidence rather than trial and error.
Precision oncology is especially worth considering for:
- Rare, advanced, or aggressive cancers
- Recurrent or treatment-resistant disease
- An unclear diagnosis, or several possible treatment paths
What the journey looks like, step by step.
Your plan is designed by a molecular tumour board, then carried out by one care team.
1. Appointment with a specialist
An organ-specific specialist reviews your history and past tests, then discusses whether precision testing could change your options.
2. Molecular and genetic testing
We arrange the right genomic and biomarker tests — a tissue sample, or a liquid biopsy when that's easier.
3. Molecular tumour board
Your medical oncologist, surgeon and a molecular genetics specialist — with pathology's input — review your results together and design your options as a team.
4. Matched treatment, closely watched
Your treatment — targeted therapy, immunotherapy or matched chemotherapy — begins in a monitored setting, with your progress checked as you go.
5. Follow-up and survivorship
Care continues after active treatment, with regular monitoring and support for the longer term.
What we look at.
Comprehensive genomic profiling (NGS panels)
Scans dozens to hundreds of genes at once, to find the alterations driving your cancer that a specific drug can target.
Key gene mutation testing
Focused tests for markers such as EGFR, ALK, KRAS, BRCA and HER2, which guide targeted therapy in lung, breast, ovarian, prostate and other cancers.
Immunotherapy biomarker testing
Markers such as PD-L1, MSI and tumour mutational burden (TMB) help show whether immunotherapy is likely to help you.
Liquid biopsy
A simple blood sample that reads tumour DNA. Useful when a tissue sample is hard to take, and for watching for recurrence or resistance over time.
Chemosensitivity and transcriptomics
Additional tests that show how your tumour cells respond to different drugs in the lab, and which genes inside the tumour are switched on — extra clues that help fine-tune your plan.
One test, several decisions.
Targeted therapy
Drugs that block the specific cancer-driving mutations found in your tumour, such as EGFR or ALK inhibitors.
Immunotherapy
Treatment that works with your immune system, chosen when the biomarkers suggest it is likely to help.
Personalised chemotherapy
Chemotherapy matched to your tumour biology, favouring the agents most likely to work for your cancer.
Hormonal therapy, where it applies
For some breast, prostate and gynaecological cancers, hormone-receptor analysis guides hormone-based treatment.
Nutrition and supportive care
The same molecular picture guides the nutrition and supportive care alongside your treatment, so everything works as one plan.
What once meant going abroad is now available in india
Genomic profiling used to mean sending samples abroad. Indian labs now run the same panels, so this can be part of your first plan — not a last resort. Insurance cover is widening too. Our team checks what your policy covers and handles the paperwork.
Precision oncology, handled by one team.
Organ-specific specialists and a multidisciplinary tumour board review your case together, so your plan reflects more than one opinion. Testing, treatment, nutrition and supportive care are coordinated by a single team rather than passed between departments, and your family is kept informed at every step.
Common questions
Is precision oncology only for advanced cancer?
It is best established in advanced and recurrent cancer, but it is increasingly used earlier to guide decisions from the start. Your specialist will tell you whether testing is likely to change your options.
Can a blood test be used instead of a biopsy?
Sometimes. A liquid biopsy can read tumour signals from a blood sample when a tissue biopsy is difficult. Your specialist decides which is right for you.
Does it affect anything besides my medication?
Yes. The same findings can shape the order of your treatment and the nutrition and supportive care alongside it, not only which drugs you receive.
How long do results take?
Molecular profiling is a laboratory process, so it takes longer than routine tests. Your care team will give you a timeline for your specific case.